Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 20 of 663 for:    SMS

Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03341195
Recruitment Status : Not yet recruiting
First Posted : November 14, 2017
Last Update Posted : November 17, 2017
Sponsor:
Collaborators:
Grand Challenges Canada
University of British Columbia
Information provided by (Responsible Party):
Dr Abdul Momin Kazi, Aga Khan University

Brief Summary:
Routine childhood immunization (RCI) in Pakistan is well below the recommended coverage of 90% with rates as low as 16% in certain regions (Pakistan DHS 2012-3). This has led to continued polio transmission, large measles outbreaks and thousands of deaths from vaccine-preventable diseases (Kazi.Bull WHO 2016). Mobile phone communication is widespread in developing countries and has proven a potential method of directly connecting pregnant women and mothers to health services (Kharbanda. Expert Review of Vaccine 2014). The investigators propose conducting a mixed methods proof of concept cluster randomized trial (CRT) to assess the effectiveness of different types of SMS messaging and automated calls to improve RCI and understand the perceptions and barriers that may affect SMS and automated call-based interventions at participants levels. the investigators will conduct the study at urban and rural sites in Pakistan. The investigators will examine an important public health question - do low cost, automated SMS, and automated messages improve RCI coverage in resource-constrained settings? Further, investigators will compare the effectiveness of reminder, educational and interactive text messages for improving RCI and will generate socio-cultural data regarding the impact of participants health beliefs that will be important for setting up the appropriate interventions in other LMICs.

Condition or disease Intervention/treatment Phase
Tuberculosis Polio Diphtheria Pertussis Tetanus Haemophilus Influenzae Type b Infection Hepatitis B Pneumococcal Infection Behavioral: SMS messages and automated calls Not Applicable

Detailed Description:

SMS text messages have shown to be effective for mobile health or mHealth having a considerable impact on disease prevention efforts in developing countries. Mobile phone and SMS texting provide an excellent solution to challenges like travel and complex intercultural contact. SMS based interventions have been quite effective in different programs, particularly in treatment adherence, smoke cessation, health care appointment attendance, antenatal care attendance and compliance with immunization. In addition adding incentives to SMS messages have shown a positive association, however, there is a cost implication for scaling up this model at a country level. Given the mobile phone access and acceptability in the LMIC, there is great potential for SMS based intervention to improve Immunization coverage in LMIC setup.

One major reservation for SMS based interventions is the level of literacy. However, there has been mixed input related to the preference of phones calls as compared to text messages in populations of low literacy and resource-constrained settings. Mobile phone text messages in local languages, pictorial messages and in combination with a phone call can further reduce this gap.

Most of the studies evaluating the impact of text messages on vaccination have been conducted in the United States with a major focus on flu vaccine among children and teenagers. The participants covered in these studies are from low income background at an academic medical center and is quite different from resource constraint settings of LMICs due to poor immunization registries and electronic records. There is limited data from LMICs set up on the role of SMS based interventions for improvement of RI coverage and conventional one-way reminder text messages were used by most of the studies as the intervention. Overall very few investigators compared reminders, educational and interactive SMS messages related to childhood vaccination uptake. Although some of the investigators have shown some behavior change for improvement in vaccination coverage, more rigorous application of health behavior change model needs to be applied to understand the impact of reminder, educational and interactive messages on behavior change related to improvement in RI coverage. Very few studies have compared the effect of educational, reminders and interactive messages in improving uptake and on-time routine immunization.

In this study the investigators would like to examine an important public health question - do low cost, automated SMS messages and calls improve RI coverage among participants in resource-constrained settings? In this study, we would like to compare the effectiveness of reminder, educational and interactive text messages and phone calls for improving RI uptake in Pakistani participants.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 3850 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Cluster randomized trial, four intervention arm and one control arm
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: To Evaluate the Role of Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan
Estimated Study Start Date : January 2018
Estimated Primary Completion Date : July 2018
Estimated Study Completion Date : September 2018


Arm Intervention/treatment
Active Comparator: 1. One way SMS messages.
Parents/caregiver will receive one way educational/reminder/proactive SMS messages related to routine immunization once a week till 20 weeks of age.
Behavioral: SMS messages and automated calls
The intervention consists of SMS and automated calls based messages

Active Comparator: 2. Two Way SMS messages
Parents/caregiver will receive two way (interactive) educational/reminder/proactive SMS messages related to routine immunization once a week till 20 weeks of age-parents will have the option to reply and receive more information related to immunization through text messages.
Behavioral: SMS messages and automated calls
The intervention consists of SMS and automated calls based messages

Active Comparator: 3. One way automated calls.
Parents/caregiver will receive one way educational/reminder/proactive automated phone call related to routine immunization once a week till 20 weeks of age.
Behavioral: SMS messages and automated calls
The intervention consists of SMS and automated calls based messages

Active Comparator: 4.Two way interactive automated calls
Parents/caregiver will receive two way (interactive) educational/reminder/proactive automated phone call related to routine immunization once a week till 20 weeks of age-parents will have the option to reply and receive more information related to immunization through phone call.
Behavioral: SMS messages and automated calls
The intervention consists of SMS and automated calls based messages

No Intervention: 5. Control Arm
One time counseling at the baseline survey.



Primary Outcome Measures :
  1. The primary outcome will measure the number of children who got vaccinated for routine immunization scheduled at 6, 10 and 14 weeks of life [ Time Frame: Vaccination status at 20th week of life of the particpants ]
    The final outcome of vaccine will be measured at 20 weeks of life, between control and intervention arm and between intervention arms


Secondary Outcome Measures :
  1. The secondary outcome will measure the mean improvement in on-time vaccination for routine immunization scheduled at 6, 10 and 14 weeks of life [ Time Frame: On-time vaccination for routine immunization scheduled at 6, 10 and 14 weeks of life ]
    The final outcome of on-time vaccination will be measured between control and intervention arm and between intervention arms



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 14 Days   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • The inclusion criteria includes being a child from the HDSS site, being less than 14 days of age with parent/guardian or at least one person in the household having a working mobile phone connection and parent/guardian providing consent to participate in the study.

Exclusion Criteria:

  • The exclusion criteria includes a child from outside HDSS area or family plans to stay in the catchment area for less than 20 weeks

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03341195


Contacts
Layout table for location contacts
Contact: Abdul M Kazi, MBBS,MPH +922134864232 momin.kazi@aku.edu

Sponsors and Collaborators
Aga Khan University
Grand Challenges Canada
University of British Columbia
Investigators
Layout table for investigator information
Principal Investigator: Abdul M Kazi, MBBS,MPH The Aga Khan University, Pakistan

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Dr Abdul Momin Kazi, Senior Instructor Research, Aga Khan University
ClinicalTrials.gov Identifier: NCT03341195     History of Changes
Other Study ID Numbers: 4320-Ped_ERC-16
First Posted: November 14, 2017    Key Record Dates
Last Update Posted: November 17, 2017
Last Verified: November 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Dr Abdul Momin Kazi, Aga Khan University:
SMS
Automated calls
Routine immunization
mHealth
Additional relevant MeSH terms:
Layout table for MeSH terms
Infection
Communicable Diseases
Tuberculosis
Diphtheria
Pneumococcal Infections
Haemophilus Infections
Hepatitis B
Hepatitis
Liver Diseases
Digestive System Diseases
Hepadnaviridae Infections
DNA Virus Infections
Virus Diseases
Hepatitis, Viral, Human
Mycobacterium Infections
Actinomycetales Infections
Gram-Positive Bacterial Infections
Bacterial Infections
Gram-Negative Bacterial Infections
Corynebacterium Infections
Streptococcal Infections
Pasteurellaceae Infections
Vaccines
Immunologic Factors
Physiological Effects of Drugs